kb 5492 has been researched along with sofalcone in 1 studies
Studies (kb 5492) | Trials (kb 5492) | Recent Studies (post-2010) (kb 5492) | Studies (sofalcone) | Trials (sofalcone) | Recent Studies (post-2010) (sofalcone) |
---|---|---|---|---|---|
8 | 0 | 0 | 88 | 5 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Niida, H; Okabe, S; Shimohara, K | 1 |
1 other study(ies) available for kb 5492 and sofalcone
Article | Year |
---|---|
Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl) p iperazine monofumarate monohydrate, on gastric lesions and gastric secretion in rats.
Topics: Animals; Anti-Ulcer Agents; Chalcone; Chalcones; Gastric Mucosa; Immersion; Male; Piperazines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological | 1990 |